Dudediligence.

Valion Bio, Inc

VBIONASDAQ · Electromedical & Electrotherapeutic Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$126,000Sep ’24$180,000Dec ’24$70,000Mar ’25$86,000Jun ’25$146,000Sep ’25
Net income, by quarter
−$1.4MSep ’24−$1.5MDec ’24−$1.5MMar ’25−$1.9MJun ’25−$2.6MSep ’25−$2.8MDec ’25−$6.2MMar ’26−$7.1MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$1.3M$1.8M$1.2M$780,000none on file
Gross profit−$38,000$299,000$287,000$2,000none on file
Operating income−$5.6M−$10.1M−$8.2M−$4.5M−$7.9M
Net income−$8.5M−$10.1M−$8.2M−$5.7M−$8.9M
Operating cash flow−$5.6M−$8.9M−$8.5M−$5.7M−$7.0M
Free cash flownone on file−$8.9M−$8.6M−$5.7M−$7.0M
Cash$13.0M$3.5M$3.4M$2.0M$12.6M
Shares outstanding9.7M96.8K86.2K556.9K2.5M